Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.

Strategies to Promote Equity in COVID-19 Antiviral Treatment

Fiscella, K., Sanders, M., Yaeger, J.

Release Date:

White Paper/Brief

Organizational Change/ Development
Healthcare Access and Quality
Tools Included
Outside U.S.

Mitigation and Prevention

This article discusses strategies to promote equity in COVID-19 antiviral treatment. It highlights the disproportionate effect of the pandemic on marginalized groups and the need to address inequities in access to antiviral medications. The authors discuss barriers to equity, such as low awareness, limited access to healthcare, scarcity of therapeutics, and treatment prioritization. They propose strategies to overcome these barriers, including community-driven outreach campaigns, addressing healthcare costs for uninsured patients, transparent allocation of therapeutics, and monitoring data to ensure equity. The article emphasizes the importance of proactive and transparent approaches to promote health equity in COVID-19 treatment.

Resource Details

Outcomes of Interest

Reduction of Health Disparities

Priority Population(s)

People Experiencing Poverty, Uninsured People

Setting(s) of Implementation


Geographic Area of Implementation

Implementation Period